1. Home
  2. CNVS vs NSRX Comparison

CNVS vs NSRX Comparison

Compare CNVS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cineverse Corp.

CNVS

Cineverse Corp.

HOLD

Current Price

$2.42

Market Cap

65.5M

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$2.78

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNVS
NSRX
Founded
2000
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Electronics/Video Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.5M
53.5M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
CNVS
NSRX
Price
$2.42
$2.78
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$9.00
$20.50
AVG Volume (30 Days)
321.0K
125.0K
Earning Date
02-17-2026
03-20-2026
Dividend Yield
N/A
N/A
EPS Growth
108.99
N/A
EPS
N/A
N/A
Revenue
$78,181,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$84.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
59.13
N/A
52 Week Low
$1.77
$2.60
52 Week High
$7.39
$9.99

Technical Indicators

Market Signals
Indicator
CNVS
NSRX
Relative Strength Index (RSI) 41.20 25.26
Support Level $2.37 N/A
Resistance Level $3.47 $6.39
Average True Range (ATR) 0.23 0.46
MACD -0.09 -0.19
Stochastic Oscillator 1.26 0.77

Price Performance

Historical Comparison
CNVS
NSRX

About CNVS Cineverse Corp.

Cineverse Corp is a main streaming technology and entertainment company. Its core business operates as a portfolio of owned and operated streaming channels with enthusiast fan bases; a large-scale aggregator and full-service distributor of feature films and television programs; and a proprietary technology software-as-a-service platform for over-the-top (OTT) app development and content distribution through subscription video-on-demand (SVOD), dedicated ad-supported (AVOD), ad-supported streaming linear (FAST) channels, social video streaming services, and audio podcasts. It generates revenue from streaming and digital, Base distribution, Podcast and other, and Other non-recurring.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: